摘要
有关脂肪组织的研究调查几十年来关注于其“储存”功能。最新证据揭示脂肪组织作为一个内分泌器官释放一系列称为脂肪因子的介质。脂肪因子的介导功能包括生理和病理作用,如调节能量代谢、免疫反应和血管内平衡以及炎症和代谢疾病(即动脉粥样硬化、糖尿病和代谢综合征概念中的肥胖)。脂肪因子水平失调已被证实是这些潜在疾病的可能共同病理机理。例如,促炎和抗炎脂肪因子之间的不平衡与肥胖、糖尿病和动脉粥样硬化等疾病中的传统危险因素 (血脂异常、高血压、胰岛素抵抗) 呈正相关。脂肪因子介导的生物活性尤其影响内皮功能障碍/激活和斑块内炎症/易损性。本综述的目的是概述脂肪因子在动脉粥样硬化形成中的作用。讨论基础研究中关于脂肪因子诱导的血管和免疫细胞亚群的调控机制和证据。最后,我们将报道与临床试验相矛盾的结果,并试图使我们更好地理解为什么有价值的基础研究结果无法快速应用于人类的动脉粥样硬化的临床试验研究。
关键词: 脂肪因子;脂联素;动脉粥样硬化;瘦素;脂肪组织
图形摘要
Current Drug Targets
Title:The Role of Adipocytokines in Atherogenesis and Atheroprogression
Volume: 16 Issue: 4
Author(s): Federico Carbone, Francois Mach and Fabrizio Montecucco
Affiliation:
关键词: 脂肪因子;脂联素;动脉粥样硬化;瘦素;脂肪组织
摘要: Research investigations on adipose tissue were focused for several decades on its “storage” function. Emerging evidence unveiled adipose tissue as an endocrine organ releasing a several mediators termed as adipokines. Adipokine-mediated functions include both physiological and pathophysiological roles such as regulation of energy metabolism, immune response and vascular homeostasis, as well as inflammatory and metabolic diseases (i.e. atherogenesis, diabetes and obesity clustered in the concept of metabolic syndrome). A dysregulation of adipokine levels has been also suggested as a potential common mechanism underlying these disorders. For instance, an unbalance between pro- and anti-inflammatory adipokines was positively associated with traditional risk factors (dyslipidaemia, hypertension, insulin resistance) in obesity, diabetes and atherogenesis. Adipokine-mediated activities particularly affected endothelial dysfunction/activation and intraplaque inflammation/vulnerability. The purpose of this narrative review is to provide an overview on the role of adipokines in atherogenesis. Evidence from basic research studies about adipokine-induced regulation of vascular and immune cell subsets will be discussed. Finally, conflicting results from clinical trials we be reported, with an attempt to better understand the reason why promising basic research results did not allow a speedy “into human” translation for clinical management of atherogenesis.
Export Options
About this article
Cite this article as:
Federico Carbone, Francois Mach and Fabrizio Montecucco , The Role of Adipocytokines in Atherogenesis and Atheroprogression, Current Drug Targets 2015; 16 (4) . https://dx.doi.org/10.2174/1389450115666141109213439
DOI https://dx.doi.org/10.2174/1389450115666141109213439 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bergamot (Citrus bergamia Risso) Flavonoids and Their Potential Benefits in Human Hyperlipidemia and Atherosclerosis: an Overview
Mini-Reviews in Medicinal Chemistry Reactive Oxygen Species in Myocardial Reperfusion Injury: From Physiopathology to Therapeutic Approaches
Current Pharmaceutical Biotechnology Opportunities and Challenges for Niosomes as Drug Delivery Systems
Current Drug Delivery Biologic Therapies in Primary Sjögren's Syndrome
Current Pharmaceutical Biotechnology Role of Vascular Progenitor Cells in Cardiovascular Disease
Current Pharmaceutical Design Retrospective, Observation Study: Quantitative and Qualitative Effect of Ezetimibe and HMG-CoA Reductase Inhibitors on LDL-Cholesterol: Are There Disappearance Thresholds for Small, Dense LDL and IDL?
Recent Patents on Cardiovascular Drug Discovery Q Fever Endocarditis
Infectious Disorders - Drug Targets Mediterranean Diet and Dementia of the Alzheimer Type
Current Aging Science Vitamin D in Atherosclerosis, Vascular Disease, and Endothelial Function
Current Drug Targets Epidemiology of Major Congenital Malformations with Specific Focus on Teratogens
Current Drug Safety Natural Compounds and Drug Discovery: Can Cnidarian Venom Play a Role?
Central Nervous System Agents in Medicinal Chemistry EGFR(s) in Aging and Carcinogenesis of the Gastrointestinal Tract
Current Protein & Peptide Science Recent Updates on the Calcium-Sensing Receptor as a Drug Target
Current Medicinal Chemistry Anemia and Chronic Kidney Disease: Making Sense of the Recent Trials
Reviews on Recent Clinical Trials The Effects of Pemafibrate in Japanese Patients with Type 2 Diabetes Receiving HMG-CoA Reductase Inhibitors
Endocrine, Metabolic & Immune Disorders - Drug Targets Blood Pressure and Vascular Alterations with Growth in Childhood
Current Pharmaceutical Design Advanced Glycation End Products (AGEs) and Cardiovascular Disease (CVD) in Diabetes
Cardiovascular & Hematological Agents in Medicinal Chemistry Analysis of QTc Interval during Levofloxacin Prescription in Cardiac Patients with Pneumonia
Current Drug Safety Detection of Klebsiella Antibodies and HLA-B27 Allelotypes Could be Used in the Early Diagnosis of Ankylosing Spondylitis with a Potential for the Use of “Low Starch Diet” in the Treatment
Current Rheumatology Reviews The Pamela Study: Old and New Findings
Current Hypertension Reviews